🔗 Permalink

Inventor profile of:

DAVID MUNN

City:

AUGUSTA, Georgia

Country:

United States

Published Applications:

Last publication date:

2014-12-25

Top Assignees for applications by DAVID MUNN

The entities that hold a legal rights for patent applications filed by inventor MUNN DAVID:

MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC 7 AUGUSTA, GA United States
Georgia Regents Research Institute, Inc. 2 Augusta, GA United States
Medical College of Georgia Research 2 Augusta, GA United States
GEORGIA HEALTH SCIENCES UNIVERSITY 2 Augusta, GA United States
MEDICAL COLLEGE OF GEORGIA 1 Augusta, GA United States
Med. College of Georgia Research Institute, Inc. 1 Augusta, GA United States
Augusta University Research Institute, Inc. 1 Augusta, GA United States

Recent patent applications by MUNN DAVID

DAVID MUNN from AUGUSTA, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-12-25

US20140377307A1

Human necessities

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

#2 | 2012-11-15

US20120288472A1

Chemistry; metallurgy

REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN

#3 | 2012-06-07

US20120142750A1

Chemistry; metallurgy

INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS

#4 | 2010-12-09

US20100311804A1

Human necessities

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

#5 | 2009-12-03

US20090297540A1

Human necessities

Induction of Indoleamine 2,3-Dioxygenase in Dendritic Cells by TLR Ligands and Uses thereof

#6 | 2009-10-06

US10780797

Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

#7 | 2009-06-18

US20090155311A1

Chemistry; metallurgy

INDOLEAMINE 2,3-DIOXYGENASE PATHWAYS IN THE GENERATION OF REGULATORY T CELLS

#8 | 2009-05-14

US20090123420A1

Human necessities

Regulation of T Cell-Mediated Immunity by D Isomers of Inhibitors of Indoleamine-2,3-Dioxygenase

#9 | 2009-03-26

US20090081155A1

Human necessities

Pharmaceutical compositions containing 1-methyl-D-tryptophan

#10 | 2007-04-05

US20070077234A1

Chemistry; metallurgy

Regulation of T cell-mediated immunity by tryptophan

#11 | 2007-04-05

US20070077224A1

Chemistry; metallurgy

Regulation of T cell-mediated immunity by tryptophan

#12 | 2007-01-09

US10112362

Regulation of T cell-mediated immunity by tryptophan

#13 | 2005-08-25

US20050186289A1

Human necessities

Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenase

InventorID:

1014241 ⎘